KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Alnylam Pharmaceuticals (ALNY) Long-Term Debt Repayments (2021 - 2022)

Historic Long-Term Debt Repayments for Alnylam Pharmaceuticals (ALNY) over the last 2 years, with Q4 2022 value amounting to -$1.5 billion.

  • Alnylam Pharmaceuticals' Long-Term Debt Repayments fell 40484.28% to -$1.5 billion in Q4 2022 from the same period last year, while for Dec 2024 it was -$1.0 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of -$762.1 million for FY2022, which is 25242.14% down from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Long-Term Debt Repayments stood at -$1.5 billion for Q4 2022, which was down 40484.28% from $500.0 million recorded in Q4 2021.
  • Alnylam Pharmaceuticals' 5-year Long-Term Debt Repayments high stood at $500.0 million for Q4 2021, and its period low was -$1.5 billion during Q4 2022.